The North Carolina Lung Cancer Initiative has awarded Carolyn Glass, MD PhD for her project titled “Identifying Epigenetic Biomarkers that Predict Response to Immunotherapy in Lung Cancer Patients” as part of the 2020 Research Fellows Program.
The purpose of the Lung Cancer Initiative’s research program is to further the development of local lung cancer care and research programs across the state, and to encourage continuing involvement in the field of lung cancer. Their Scientific Advisory Committee selects one project from each of the five participating institutions.